Noxopharm Limited

NOXOF · OTC
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Activities
Net Income-$4-$15-$19-$9
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$0-$1-$2
Stock-Based Comp.$0$0$1$2
Change in WC$4-$1-$5$4
Other Non-Cash-$1$5$10-$3
Operating Cash Flow-$1-$11-$14-$9
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$2$0$0$0
Stock Issued$0$0$1$29
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$0-$0-$0
Financing Cash Flow$0-$0$1$28
Forex Effect-$0-$0-$0-$0
Net Chg. in Cash-$1-$11-$13$20
Supplemental Information
Beg. Cash$3$14$27$7
End Cash$2$3$14$27
Free Cash Flow-$1-$11-$14-$9
Noxopharm Limited (NOXOF) Financial Statements & Key Stats | AlphaPilot